First Turn Management »

Bicara Therapeutics shares owned by First Turn Management

Quarter-by-quarter ownership of Bicara Therapeutics shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by First Turn Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $14M 562k 25.47

More positions owned by First Turn Management

Nuvalent Inc-a (NUVL)
Argenx Se Sponsored Adr (ARGX)
Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals (MIRM)
Vaxcyte (PCVX)
Axsome Therapeutics (AXSM)
Syndax Pharmaceuticals (SNDX)
Ascendis Pharma A/s Sponsored Adr (ASND)
Natera (NTRA)
Intra Cellular Therapies (ITCI)
Crinetics Pharmaceuticals In (CRNX)
Transmedics Group (TMDX)
Arcellx Common Stock (ACLX)
Blueprint Medicines (BPMC)
Verona Pharma Sponsored Ads (VRNA)

View all positions for First Turn Management

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Tpg Gp A
Deerfield Management Company
Braidwell
T. Rowe Price Associates
Fairmount Funds Management
Baker Bros. Advisors
Blackstone Group
First Turn Management
Vestal Point Capital
Point72 Asset Management
Woodline Partners
OrbiMed Advisors
Citadel Advisors

View all funds holding Bicara Therapeutics